Tumor Necrosis Factor Soluble Receptor 75: The Principal Receptor Form Released by Human Alveolar Macrophages and Monocytes in the Presence of Interferon γ

American Journal of Respiratory Cell and Molecular Biology

Volumn 14, Issue 3, 1996, Pages 279-287

  Galve de Rochemonteix, Beatrice ^b   Nicod, Laurent P ^b   Dayer, Jean Michel ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; COLCHICINE; GAMMA INTERFERON; GROWTH PROMOTOR; LEUKOCYTE ANTIGEN; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONENSIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN SYNTHESIS INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CULTURE MEDIUM; DRUG EFFECT; HUMAN; L CELL; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; METABOLISM; MICROTUBULE; MONOCYTE; MOUSE;

ANIMALS; ANTIGENS, CD; CELLS, CULTURED; CHLOROQUINE; COLCHICINE; CULTURE MEDIA; GROWTH SUBSTANCES; HUMANS; INTERFERON TYPE II; L CELLS (CELL LINE); LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES, ALVEOLAR; MICE; MICROTUBULES; MONENSIN; MONOCYTES; PROTEIN SYNTHESIS INHIBITORS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030098853     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.14.3.8845179     Document Type: Article

References (48)

1. Carswell, E. A., L. J. Old, R. L. Kassel, S. Green, N. Fiore, and B. Williamson. 1975. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72:3666-3670.
2. Old, L. J. 1985. Tumor necrosis factor. Science 230:630-632.
3. Vilcek, J., and T. H. Lee. 1991. Tumor necrosis factor. J. Biol. Chem. 266:7313-7316.
4. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411-452.
5. 2 production by human synovial cells and dermal fibroblasls. J. Exp. Med. 162:2163-2168.
6. Loetscher, H., Y.-C. Pan, H.-W. Lahm, R. Gentz, M. Brockhaus, H. Tabucchi, and W. Lesslauer. 1990. Molecular cloning and expression of the human 55 kD tumor necrosis factor receptor. Cell 61:351-359.
7. Schall, T. J., M. Lewis, K. J. Koller, A. Lee, G. C. Rice, G. H. W. Wong, T. Gatanaga, G. A. Granger, R. Lentz, H. Raab, W. J. Kohr, and D. V. Goeddel. 1990 Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61:361-370.
8. Beutler, B., and C. van Huffel. 1994. Unraveling function in the TNF ligand and receptor family. Science 264:667-668.
9. Brockhaus, M., H.-J. Schoenfeld, E.-J. Schlaeger, W. Hunziger, W. Lesslauer, and H. Loetscher. 1990. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 87:3127-3131.
10. Nicod, L. P., B. Galve-de Rochemonteix, and J.-M. Dayer. 1994. Modulation of IL-1 receptor antagonist and TNF-soluble receptors produced by alveolar macrophages and blood monocytes. Ann. NY Acad. Sci. 725: 323-330.
11. Porteu, F., and C. Nathan. 1990. Shedding of tumor necrosis factor receptors by activated human neutrophils. J. Exp Med. 172:599-607.
12. Porteu, F., M. Brockhaus, D. Wallach, H. Engelmann, and C. F. Nathan. 1991. Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor. J. Biol. Chem. 28: 18846-18853.
13. Crowe, P. D., B. N. Walter, K. M. Mohler, C. Otten-Evans, R. A. Black, and C. F. Ware. 1995. A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. J. Exp. Med. 181:1205-1210.
14. Seckinger, P., S. Isaaz, and J.-M. Dayer. 1988. A human inhibitor of tumor necrosis factor α. J. Exp. Med. 167:1511-1516.
15. Olsson, I., M. Lantz, E. Nilsson, C. Peetre, H. Thysell, A. Grubb, and G. Adolf. 1989 Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur. J. Haematol. 42:270-275.
16. Seckinger, P., J. H. Zhang, B. Hauptmann, and J.-M. Dayer. 1990. Characterization of a tumor necrosis factor α (TNFα) inhibitor: evidence of immunological cross-reactivity with the TNF-receptor. Proc. Natl. Acad. Sci. USA 87:5188-5192.
17. Engelmann, H., D Aderka, M. Rubinstein, D. Rotman, and D. Wallach. 1989. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor. J. Biol. Chem. 264:11974-11980.
18. Seckinger, P., S. Isaaz, and J.-M. Dayer. 1989. Purification and biologic characterization of a specific tumor necrosis factor or inhibitor. J. Biol. Chem. 264:11966-11973.
19. Dembie, Z., H. Loetscher, U. Gubler, Y. E. Pan, H. Lahm, R. Gentz, M. Brockhaus, and W. Lesslauer. 1990. Two human TNF receptors have similar extracellular, but distinct intracellular domain sequences. Cytokines 2:231-237.
20. Higuchi, M., and B. B. Aggarwal. 1992. Modulation of two forms of tumor necrosis factor receptors and their cellular response by soluble receptors and their monoclonal antibodies. J. Biol. Chem. 267:20892-20899.
21. Aderka, D., H. Engelmann, Y. Maor, C. Brakebusch, and D. Wallach. 1992. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J. Exp. Med. 175:323-329.
22. Mohler, K. M., D. S. Torrance, C. A. Smith, R. G. Goodwin, K. E. Stremler, V. P. Fung, H. Madani, and M. B. Widmer. 1993. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J. Immunol. 151:1548-1561.
23. Galve-de Rochemonteix, B., J.-M. Dayer, and A. F. Junod. 1990. Fibroblast-alveolar cell interactions in sarcoidosis and idiopathic pulmonary fibrosis: evidence for stimulatory and inhibitory cytokine production by alveolar cells. Eur. Respir. J. 3:653-664.
24. Aggarwal, B. B., T. E. Eessalu, and P. E. Hass. 1985. Characterization of receptors for human tumor necrosis factor and their regulation by gamma-interferon. Nature 318:665-667.
25. Malkovsky, M., B. Loveland, M. North, G. L. Asherson, P. Ward, and W. Fiers. 1987. Recombinant interleukin 2 directly augments the cytotoxicity of human monocytes. Nature 325:362-364.
26. Nedwin, G. E., L. P. Svedersky, T. S. Brinkman, M. A. Palladino, and D. V. Goeddel. 1985. Effect of interleukin 2, interferon γ and mitogens on the production of tumor necrosis factor α and β. J. Immunol. 135: 2492-2497.
27. Galve-de Rochemonteix, B., L. P. Nicod, R. Chicheportiche, S. Lacraz, C. Baumberger, and J.-M. Dayer. 1993. Regulation of interleukin-1Ra, interleukin-1α and interleukin-10 production by human alveolar macrophages with phorbol myristate acetate, lipopolysaccharide and interleukin-4. Am. J. Respir. Cell Mol. Biol. 8:160-168.
28. Girardin, E., P. Roux-Lombard, G. E. Grau, P. Suter, H. Gallati, the J5 Study Group, and J.-M. Dayer. 1992. Imbalance between tumor necrosis factor a and soluble TNF receptor concentrations in severe meningococcaemia. Immunology 76:20-23.
29. Roux-Lombard, P., H.-C. Lin, J. B. Peter, J.-M. Dayer. 1994. Elevated serum levels of TNF soluble receptors in patients with positive anti-neutrophil cytoplasmic antibodies. Br. J. Rheumatol. 33:428-431.
30. Winzen, R., D. Wallach, O. Kemper, K. Resch, and H. Holtmann. 1993. Selective up regulation of the 75-kDa tumor necrosis factor (TNF) receptor and its mRNA by TNF and IL-1. J. Immunol. 150:4346-4353.
31. Lindvall, L., M. Lantz, U. Gullberg, and I. Olsson. 1990. Modulation of the constitutive gene expression of the 55 kD tumor necrosis factor receptor in hematopoietic m cells. Biochem. Biophys. Res. Commun. 152:557-563.
32. Winzen, R., D. Wallach, H. Engelmann, Y. Nophar, C. Brakebusch, O. Kemper, K. Resch, and H. Holtmann. 1992. Selective decrease in cell surface expression and mRNA level of the 55-kDa tumor necrosis factor receptor during differentiation of HL-60 cells into macrophage-like but not granulocyte-like cells. J. Immunol. 148:3454-3460.
33. Villard J., P. Roux-Lombard, A. Hugh, and J.-M. Dayer. 1993. Could natural inhibitors of tumor necrosis factor-alpha modify the clinical course of fulminant meningococcemia? Crit. Care Med. 21:1396-1400.
34. Bemelmans, M. H. A., D. J. Gouma, W. A. Buurman. 1993. Influence of nephrectomy on tumor necrosis factor clearance in a murine model. J. Immunol. 150:2007-2017.
35. Carpentier, J.-L., J.-M. Dayer, U. Lang, R. Silvermann, L. Orci, and P. Gorden. 1984. Down-regulation and recycling of insulin receptors. Effect of monensin on IM-9 lymphocytes and U-937 monocyte-like cells. J. Biol. Chem. 259:14190-14195.
36. Kodavanti, U. P., and H. M. Mehendale. 1990. Cationic amphilic drugs and phospholipid storage disorder. Pharmacol. Rev. 42:327-354.
37. Hwang, C., M. Gatanaga, G. A. Granger, and T. Gatanaga. 1993. Mechanism of release of soluble forms of tumor necrosis factor/lymphokine receptors by phorbol myristate-stimulated human THP-1 cells in vitro. J. Immunol. 151:5631-5638.
38. Ding, A., E. Sanchez, M. Tancinco, and C. Nathan. 1992. Interactions of bacterial lipopolysaccharide with microtubule proteins. J. Immunol. 148: 2853-2858.
39. Ding, A., E. Sanchez, and C. Nathan. 1993. Taxol shares the ability of bacterial lipopolysaccharide to induce tyrosine phosphorylation of microtubule-associated protein kinase. J. Immunol. 151:5596-5602.
40. Leeuwenberg, J. F. M., M. A. Dentener, and W. A. Buurman. 1994. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. J. Immunol. 152:5070-5076.
41. Pandita, R., E. Pocsik, and B. B. Aggarwal. 1992. Interferon-γ induces cell surface expression for both types of tumor necrosis factor receptors. FEBS Lett. 312:87-90.
42. Leeuwenberg J. F. M., T. M. A. A. Jeunhomme, and W. A. Buurman. 1994. Slow release of soluble TNF receptors by monocytes in vitro. J. Immunol. 152:4036-4043.
43. Taylor, D. J. 1994. Cytokine combinations increase p75 tumor necrosis factor receptor binding and stimulate receptor shedding in rheumatoid synovial fibroblasts. Arthritis Rheum. 37:232-235.
44. Joyce, D. A., D. P. Gibbons, P. Green, J. H. Steer, M. Feldmann, and F. M. Brennan. 1994. Two inhibitors of pro-inflammatory cytokine release. interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis actor receptor by cultured monocytes. Eur. J. Immunol. 24:2699-2705.
45. Taylor, D. J. 1994. Interleukin-4 (IL-4) induces down-modulation and shedding of the p55 tumour necrosis factor receptor and inhibitis TNFα's effect on rheumatoid synovial fibroblasts. Rheumatol. Int. 14:21-25.
46. Bemelmans, M. H. A., D. J. Gouma, and W. A. Buurman. 1993. LPS-induced sTNF-receptor release in vivo in a murine model. J. Immunol. 151:5554-5562.
47. Tilg, H., W. Vogel, and C. A. Dinarello. 1995. Interferon-α induces circulating tumor necrosis factor receptor p55 in humans. Blood 85:433-435.
48. Klein, B., and H. Brailly. 1995. Cytokine-binding proteins: stimulating antagonists. 1995. Immunol. Today 16:216-220.